2026-01-11 22:26:28

Tech giants are pouring billions of dollars into AI research, but mainly for entertainment purposes. Meanwhile, funding and computing power for truly human-related issues like cancer research, climate modeling, and drug discovery are pitifully scarce.

The problem isn't that AI technology itself isn't mature enough—today's AI is already sufficient. The real issue lies in the business model. Profitable and quickly effective avenues naturally attract capital, while fundamental research with long return cycles and unclear commercialization paths receives little investor interest.

This is a classic example of an incentive mechanism imbalance. How can we reverse this situation? How can we redesign economic incentives to direct the brightest minds and the most powerful tools to where they are needed most? This is a question worth serious consideration.

View Original

This page may contain third-party content, which is provided for information purposes only (not representations/warranties) and should not be considered as an endorsement of its views by Gate, nor as financial or professional advice. See Disclaimer for details.

10 Likes

Reward
10
5
Repost
Share

Comment

0/400

metaverse_hermit

· 14h ago

Basically, it's capital seeking profits, nothing new AI rebranding and selling skins is much more profitable than saving lives; the math is very clear Imbalanced incentive mechanisms? That's a systemic issue; mere appeals won't help If you really want change, policy intervention is needed, but who dares to make a move?

View OriginalReply0

LongTermDreamer

· 14h ago

Haha, I mentioned this three years ago, and now someone finally wrote about it. The crypto world has long seen through it—it's a game between quick money and long-term strategies, that's the cyclical pattern, brother. But to be honest, cancer research really should have a DAO to handle it; decentralized funding models are much more reliable than traditional VCs.

View OriginalReply0

JustHodlIt

· 14h ago

Basically, it's just capital seeking profits, who cares about saving lives Under capitalism, this is inevitable, short-term gains always win Forget it, blockchain is the same... Is there a charity chain? No Look at it from another perspective, medical AI is actually harder to commercialize, it has to lose money Pharmaceutical companies should have taken action long ago, who to blame for not having the funds? Isn't this exactly why we need DAOs, decentralized incentive mechanisms It's just that the incentives are misguided, reversed

View OriginalReply0

TrustMeBro

· 15h ago

Capital is like this, always chasing short-term gains. The medical and climate sectors are big and difficult to tackle, and investors are not willing to wait ten or eight years. To put it simply, this is not a technical issue, but a human nature problem. We need to find a way to label long-term research with quick monetization potential, otherwise it will never get the chance. How can this be changed unless the government directly invests money in R&D, but current politicians... you know. What might truly save this situation are radical new business models. For example, using tokens for incentives and impact investing—could it work? Honestly, I’m not very optimistic.

View OriginalReply0

CafeMinor

· 15h ago

Capital pursuit of profit is a natural law, but while using AI to create memes, no one is researching the damn diseases that humans suffer from. This philosophical issue is a big one.

View OriginalReply0